Clinical Trials Browser

Interventional × Anemia, Refractory × Thalidomide × Clear all

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00015990 2013-01-24

Thalidomide in Treating Patients With Myelodysplastic Syndrome

Phase 2 Completed

29 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

Clinical Trials

Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome

Thalidomide in Treating Patients With Myelodysplastic Syndrome